Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

210 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New Findings on Presentation and Outcome of Patients With Adrenocortical Cancer: Results From a National Cohort Study.
Puglisi S, Calabrese A, Ferraù F, Violi MA, Laganà M, Grisanti S, Ceccato F, Scaroni C, Di Dalmazi G, Stigliano A, Altieri B, Canu L, Loli P, Pivonello R, Arvat E, Morelli V, Perotti P, Basile V, Berchialla P, Urru S, Fiori C, Porpiglia F, Berruti A, Pia A, Reimondo G, Cannavò S, Terzolo M. Puglisi S, et al. Among authors: ferrau f. J Clin Endocrinol Metab. 2023 Sep 18;108(10):2517-2525. doi: 10.1210/clinem/dgad199. J Clin Endocrinol Metab. 2023. PMID: 37022947
Persistent severe visual field impairment is associated with obesity and tumour invasiveness, but not with pituitary dysfunction, in patients with craniopharyngioma.
Giovinazzo S, Oliverio G, Cotta OR, Alessi Y, Angileri FF, Ferreri F, Certo R, De Maria A, Alibrandi A, Aragona P, Cannavò S, Ferraù F. Giovinazzo S, et al. Among authors: ferrau f. Endocrine. 2023 Jul;81(1):50-53. doi: 10.1007/s12020-023-03359-x. Epub 2023 Apr 11. Endocrine. 2023. PMID: 37040006
Endocrine disruptors, aryl hydrocarbon receptor and cortisol secretion.
Pecori Giraldi F, Ferraù F, Ragonese M, Cannavò S. Pecori Giraldi F, et al. Among authors: ferrau f. J Endocrinol Invest. 2024 Apr 18. doi: 10.1007/s40618-024-02371-w. Online ahead of print. J Endocrinol Invest. 2024. PMID: 38637430 Free article. Review.
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study).
Antonelli A, Palumbo C, Noale M, Artibani W, Bassi P, Bertoni F, Bracarda S, Bruni A, Corvò R, Gacci M, Magrini SM, Montironi R, Porreca A, Tubaro A, Zagonel V, Maggi S; Pros-IT CNR study group. Antonelli A, et al. Minerva Urol Nefrol. 2020 Oct;72(5):595-604. doi: 10.23736/S0393-2249.19.03637-3. Epub 2020 Jan 7. Minerva Urol Nefrol. 2020. PMID: 31920063 Free article.
Resistance to Somatostatin Analogs in Italian Acromegaly Patients: The MISS Study.
Berton AM, Prencipe N, Bertero L, Baldi M, Bima C, Corsico M, Bianchi A, Mantovani G, Ferraù F, Sartorato P, Gagliardi I, Ghigo E, Grottoli S. Berton AM, et al. Among authors: ferrau f. J Clin Med. 2022 Dec 20;12(1):25. doi: 10.3390/jcm12010025. J Clin Med. 2022. PMID: 36614826 Free PMC article.
Trabecular bone score, bone marrow fat and vertebral fractures in cushing syndrome.
Ferraù F, Giovinazzo S, Alessi Y, Catalano A, Tessitore A, Mormina E, Bellone F, Giuffrida G, Paola G, Cotta OR, Ragonese M, Granata F, Lania AG, Mazziotti G, Cannavò S. Ferraù F, et al. Endocrine. 2023 May;80(2):441-447. doi: 10.1007/s12020-023-03318-6. Epub 2023 Feb 15. Endocrine. 2023. PMID: 36790522
Proteasome inhibitors in medullary thyroid carcinoma: time to restart with clinical trials?
Fanciulli G, Modica R, La Salvia A, Grossrubatscher EM, Florio T, Ferraù F, Veresani A, Russo F, Colao A, Faggiano A. Fanciulli G, et al. Among authors: ferrau f. Front Endocrinol (Lausanne). 2023 Apr 20;14:1145926. doi: 10.3389/fendo.2023.1145926. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37152939 Free PMC article. Review.
The Italian Rare Biliary tract Cancer initiative (IRaBiCa): A multicentric observational study of Gruppo Oncologico dell'Italia Meridionale (GOIM) in collaboration with Gruppo Italiano Colangiocarcinoma (GICO).
Speranza D, Sapuppo E, Aprile G, Auriemma A, Bergamo F, Bianco R, Bordonaro R, Brandi G, Brunetti O, Carnaghi C, Ciliberto D, Cinieri S, Corallo S, De Vita F, Di Donato S, Ferraù F, Fornaro L, Barucca V, Giommoni E, Lotesoriere C, Luchini C, Masini C, Niger M, Pisconti S, Rapposelli IG, Rimassa L, Rognone C, Rodriquenz MG, Corsini LR, Santin D, Scarpa A, Scartozzi M, Soto Parra H, Tonini G, Tortora G, Tralongo P, Silvestris N. Speranza D, et al. Among authors: ferrau f. Tumori. 2024 Feb 7:3008916231222761. doi: 10.1177/03008916231222761. Online ahead of print. Tumori. 2024. PMID: 38326240
A pharmacoeconomic analysis from Italian guidelines for the management of prolactinomas.
Basile M, Valentini I, Attanasio R, Cozzi R, Persichetti A, Samperi I, Scoppola A, Auriemma RS, De Menis E, Esposito F, Ferrante E, Iatì G, Mazzatenta D, Poggi M, Rudà R, Tortora F, Cruciani F, Mitrova Z, Saulle R, Vecchi S, Cappabianca P, Paoletta A, Bozzao A, Caputo M, Doglietto F, Ferraù F, Lania AG, Laureti S, Lello S, Locatelli D, Maffei P, Minniti G, Peri A, Ruini C, Settanni F, Silvani A, Veronese N, Grimaldi F, Papini E, Cicchetti A. Basile M, et al. Among authors: ferrau f. Glob Reg Health Technol Assess. 2024 Jan 9;11:1-16. doi: 10.33393/grhta.2024.2601. eCollection 2024 Jan-Dec. Glob Reg Health Technol Assess. 2024. PMID: 38230389 Free PMC article.
210 results